The Effect of Far-Infrared Therapy on the Peritoneal Expression of Glucose Degradation Products in Diabetic Patients on Peritoneal Dialysis

被引：0
|
作者：
Lin, Chih-Ching [1 ]
Niu, Chih-Yuan [1 ]
机构：
[1] Taipei Vet Gen Hosp, Taipei, Taiwan
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2021年 / 32卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PO0986
引用
收藏
页码：333 / 333
页数：1
相关论文
共 50 条
  • [41] Fate of the glucose degradation products 3-deoxyglucosone and glyoxal during peritoneal dialysis
    Tauer, A
    Bender, TO
    Fleischmann, EH
    Niwa, T
    Jörres, A
    Pischetsrieder, M
    MOLECULAR NUTRITION & FOOD RESEARCH, 2005, 49 (07) : 710 - 715
  • [42] Affinity adsorption of glucose degradation products improves the biocompatibility of conventional peritoneal dialysis fluid
    Ishikawa, N
    Miyata, T
    Ueda, Y
    Inagi, R
    Izuhara, Y
    Yuzawa, H
    Onogi, H
    Nishina, M
    Nangaku, M
    de Strihou, CV
    Kurokawa, K
    KIDNEY INTERNATIONAL, 2003, 63 (01) : 331 - 339
  • [43] A STUDY OF THE CLINICAL AND BIOCHEMICAL PROFILE OF PERITONEAL DIALYSIS FLUID LOW IN GLUCOSE DEGRADATION PRODUCTS
    Lai, Kar Neng
    Lam, Man Fai
    Leung, Joseph C. K.
    Chan, Loretta Y.
    Lam, Christopher W. K.
    Chan, Iris H. S.
    Chan, Hoi Wong
    Li, Chun Sang
    Wong, Sunny S. H.
    Ho, Yiu Wing
    Cheuk, Au
    Tong, Matthew K. L.
    Tang, Sydney C. W.
    PERITONEAL DIALYSIS INTERNATIONAL, 2012, 32 (03): : 280 - 291
  • [44] Effect of Peritoneal Transport Characteristics on Clinical Outcome in Nondiabetic and Diabetic Nephropathy Patients with Peritoneal Dialysis
    Wang, Hong
    Tian, Junping
    Du, Fenghe
    Wang, Tao
    IRANIAN JOURNAL OF KIDNEY DISEASES, 2019, 13 (01) : 56 - 66
  • [45] Effect of peritoneal glucose load on plasma leptin concentration in continuous ambulatory peritoneal dialysis patients
    Kim, MJ
    Kim, GA
    Lee, SW
    Song, JH
    Hyun, IY
    YONSEI MEDICAL JOURNAL, 2000, 41 (04) : 485 - 490
  • [46] Expression of membrane complement regulators in patients on peritoneal dialysis therapy
    Sei, Y.
    Mizuno, M.
    Imai, M.
    Suzuki, Y.
    Higashide, K.
    Okada, N.
    Harris, C.
    Matsuo, S.
    Ito, Y.
    MOLECULAR IMMUNOLOGY, 2013, 56 (03) : 277 - 278
  • [47] Mesothelial toxicity of peritoneal dialysis fluids is related primarily to glucose degradation products, not to glucose per se
    Witowski, J
    Bender, TO
    Wisniewska-Elnur, J
    Ksiazek, K
    Passlick-Deetjen, J
    Breborowicz, A
    Jörres, A
    PERITONEAL DIALYSIS INTERNATIONAL, 2003, 23 (04): : 381 - 390
  • [48] Effect of glucose degradation products on human peritoneal mesothelial cell function
    Witowski, J
    Korybalska, K
    Wisniewska, J
    Breborowicz, A
    Gahl, GM
    Frei, U
    Passlick-Deetjen, J
    Jörres, A
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2000, 11 (04): : 729 - 739
  • [49] Randomized, Controlled Trial of Glucose-Sparing Peritoneal Dialysis in Diabetic Patients
    Li, Philip K. T.
    Culleton, Bruce F.
    Ariza, Amaury
    Do, Jun-Young
    Johnson, David W.
    Sanabria, Mauricio
    Shockley, Ty R.
    Story, Ken
    Vatazin, Andrey
    Verrelli, Mauro
    Yu, Alex W.
    Bargman, Joanne M.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2013, 24 (11): : 1889 - 1900
  • [50] Peritoneal dialysis using icodextrin improves plasma glucose concentrations in diabetic patients
    Teising, Mary
    McGreevy, Rona
    NEPHROLOGY NURSING JOURNAL, 2006, 33 (02) : 143 - 143
12345